News Post List
The new NHS England funding boost from the Prime Minister needs to focus on staff shortages to make a difference in cancer care.
News digest – trial to test lung cancer vaccine, cervical screening language, prostate cancer spit test and AI for the NHS
In this week’s headlines: we launch a new trial testing a lung cancer vaccine and kids in England have already reached their sugar limit for the year.
We've launched a campaign for more NHS staff to diagnose and treat cancer. Cancer survivor Elizabeth Bailey explains how you can get involved.
A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.
Top stories this week: A breast cancer immunotherapy first and lung cancer immunotherapy approved for NHS use in England.
Cancer Research UK has appointed Tony Hickson as the charity’s new chief business officer.
The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.
Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins.
Older breast cancer patients in England less likely to survive than in four other European countries
Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands.
The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.